or
forgot password

    • cancer clinical trials in bakersfield, CA

    • Study of EC145 in Patients With Advanced Ovarian and Endometrial Cancers
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Ovarian Cancer, Endometrial Cancer
    Study of EC145 in Patients With Progressive Adenocarcinoma of the Lung
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Adenocarcinoma of the Lung
    A Study of Ramucirumab in Patients With Metastatic Renal Cell Carcinoma
    ImClone Investigational Site
    Bakersfield, California 93309
    Metastatic Renal Cell Carcinoma
    A Study of Ramucirumab With or Without Dacarbazine in Metastatic Malignant Melanoma
    ImClone Investigational Site
    Bakersfield, California 93309
    Metastatic Malignant Melanoma
    Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America
    GSK Investigational Site
    Bakersfield, California 93309
    Human Papillomavirus (HPV) Infection, Papillomavirus Vaccines
    A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Multiple Myeloma
    Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Breast
    Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Non-small Cell Lung Cancer
    A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
    GSK Investigational Site
    Bakersfield, California 93309
    Nausea and Vomiting, Nausea and Vomiting, Chemotherapy-Induced
    Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Non-small Cell Lung Cancer
    Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With Chronic ITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Idiopathic Thrombocytopenic Purpura
    Study of IMC-1121B (Ramucirumab) in Patients With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy
    ImClone Investigational Site
    Bakersfield, California 93309
    Hepatocellular Carcinoma
    Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Primary Peritoneal Carcinoma, Epithelial Ovarian Carcinoma, Neoplasms, Ovarian, Fallopian Tube Cancer
    A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer
    ImClone Investigational Site
    Bakersfield, California 93309
    Prostate Cancer
    Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Breast
    APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Pancreatic Cancer, Metastatic Pancreatic Cancer
    Study of GSK1363089 in Metastatic Gastric Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Gastrointestinal Tract
    A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
    GSK Investigational Site
    Bakersfield, California 93309
    Carcinoma, Renal Cell
    A Study of Ramucirumab With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer
    ImClone Investigational Site
    Bakersfield, California 93309
    Non Small Cell Lung Cancer
    A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Non-Small Cell Lung Cancer
    Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US
    GSK Investigational Site
    Bakersfield, California 93309
    Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
    VEG111485: A QTc Study of Pazopanib
    GSK Investigational Site
    Bakersfield, California 93309
    Carcinoma, Renal Cell, Solid Tumors
    Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer
    Comprehensive Blood and Cancer Center Dept CBCC (3)
    Bakersfield, California 93309
    Metastatic Breast Cancer
    Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia Subjects
    GSK Investigational Site
    Bakersfield, California 93309
    Leukaemia, Lymphocytic, Chronic
    A Study of Pegylated Liposomal Doxorubicin (PLD), Bortezomib, Dexamethasone and Lenalidomide for Patients With Relapsed/Refractory Multiple Myeloma
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Relapsed/Refractory Multiple Myeloma
    Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Anemia, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small-Cell Lung, Bladder Cancer, Cancer of Head and Neck, Uterine Cervical Cancer
    A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
    Bakersfield Dermatology and Skin Cancer Medical Group
    Bakersfield, California 93309
    Psoriasis